Drugmaker Pfizer Inc. is aiming to boost sales of veterinary medicines in China — and its global dominance in the animal health business — via a joint venture with a Chinese startup company.
Pfizer said Thursday that it has reached a deal to jointly develop, manufacture and sell vaccines for animals with Jilin Guoyan Animal Health Company Ltd.
The joint venture, called Jilin Pfizer Guoyuan Animal Health Co., plans to start marketing its first product — a vaccine against a reproductive and respiratory condition pigs get — next year.
Executives from Pfizer and the Chinese company are reviewing options and planning future strategy. That could include developing additional vaccines for pigs, poultry, cattle and perhaps pets, as well as new animal medicines. All will target diseases common in China.
Read the full article by LINDA A. JOHNSON, AP Business Writer
No comments:
Post a Comment